Literature DB >> 12819770

Crystal structure of the apoptosis-inducing human granzyme A dimer.

Clara Hink-Schauer1, Eva Estébanez-Perpiñá, Florian C Kurschus, Wolfram Bode, Dieter E Jenne.   

Abstract

Granzyme A (GzmA) belongs to a family of trypsin-like serine proteases localized in cytoplasmic granules of activated lymphocytes and natural killer (NK) cells. In contrast to the related granzyme B (GzmB), GzmA forms a stable disulfide-linked homodimer and triggers target-cell death in a caspase-independent way. Limited proteolysis of a high-molecular-mass complex containing SET (also named putative HLA-associated protein II or PHAPII), PHAPI (pp32, leucine-rich acidic nuclear protein) and HMG2 by GzmA liberates NM23-H1, a Mg2+-dependent DNase that causes single-stranded breaks in nuclear DNA. By analyzing the dimeric GzmA structure at a resolution of 2.5 A, we determined the substrate-binding constraints and selective advantages of the two domains arranged as a unique functional tandem. The active sites of the two subunits point in opposite directions and the nearby noncatalytic surfaces can function as exosites, presenting substrates to the active site region of the adjacent partner in a manner analogous to staphylokinase or streptokinase, which present plasminogen to the cofactor-plasmin and cofactor-plasminogen complexes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819770     DOI: 10.1038/nsb945

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  24 in total

1.  On the accuracy of unit-cell parameters in protein crystallography.

Authors:  Zbigniew Dauter; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-10-31

2.  Equilibrium unfolding of kinetically stable serine protease milin: the presence of various active and inactive dimeric intermediates.

Authors:  Subhash Chandra Yadav; Medicherla V Jagannadham; Suman Kundu
Journal:  Eur Biophys J       Date:  2010-03-24       Impact factor: 1.733

Review 3.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  Alterations in RNA processing during immune-mediated programmed cell death.

Authors:  Danielle K Rajani; Michael Walch; Denis Martinvalet; Marshall P Thomas; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-15       Impact factor: 11.205

5.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

6.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

7.  Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.

Authors:  Alexandra C Vrazo; Adrianne E Hontz; Sarah K Figueira; Braeden L Butler; Julie M Ferrell; Brock F Binkowski; Jinzhu Li; Kimberly A Risma
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

8.  Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nucleic acid binding proteins.

Authors:  Marshall P Thomas; Jennifer Whangbo; Geoffrey McCrossan; Aaron J Deutsch; Kimberly Martinod; Michael Walch; Judy Lieberman
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

9.  SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.

Authors:  Jason Z Niehaus; Mark T Miedel; Misty Good; Allyson N Wyatt; Stephen C Pak; Gary A Silverman; Cliff J Luke
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

10.  Conformational changes in redox pairs of protein structures.

Authors:  Samuel W Fan; Richard A George; Naomi L Haworth; Lina L Feng; Jason Y Liu; Merridee A Wouters
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.